Triptans and NSAIDs remain first choice for migraine: review

Triptans and NSAIDs remain the primary choices to reduce pain and improve function in the acute treatment of episodic migraine in patients who do not have contraindications. A systematic review and meta-analysis of data from more than 28,000 participants across 115 trials and 15 systematic reviews showed high and moderate strength evidence for the two ...

Already a member?

Login to keep reading.

© 2021 the limbic